On the other hand, the treatment of the skin of the mouse strain carrying active Hras with TPA led to the development of multiple papillomas, some of which developed further to cSCC, providing evidence for the oncogenic role of Hras in cSCC [57]. This evidence concerns the gene HRAS and papilloma.